Janus Henderson Group plc 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 11:44 am Purchase | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 5,503,349 5.200% | 221,195 (+4.19%) | Filing |
| 2025-05-14 12:29 pm Purchase | 2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 5,282,154 5.600% | 298,214 (+5.98%) | Filing |
| 2025-02-14 11:24 am Purchase | 2024-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX | JANUS HENDERSON GROUP PLC JHG | 4,983,940 5.300% | 4,983,940 (New Position) | Filing |